Literature DB >> 7607217

Distribution and activity of calcineurin in rat tissues. Evidence for post-transcriptional regulation of testis-specific calcineurin B.

Q Su1, M Zhao, E Weber, H P Eugster, B Ryffel.   

Abstract

Calcineurin (CN), a Ca2+/calmodulin-regulated phosphatase 2B, plays an important role in many biological processes including T-cell signal transduction. In the present study, the distribution and activity of CN were investigated in rat tissues. CN has a wide tissue distribution, as measured by enzyme-linked immunosorbent assay. CN concentrations are 0.2-0.6 micrograms/mg protein in most tissues, while the brain contains 3-10-fold higher concentrations. Immunohistochemical analyses using a monoclonal antibody to CN B subunit reveals that CN is not evenly distributed but concentrated in specific cells, especially in the brain, kidneys and testis. The specific enzymic activity of CN in tissues is around 10 pmol.min.mg protein-1, except in brain and liver (60 pmol.min-1.mg protein-1 compared to 3.6 pmol.min-1.mg protein-1). The immunosuppressants cyclosporin A and tacrolimus, but not rapamycin, inhibit the phosphatase activity of CN derived from most tissues tested, while CN activity from liver was resistant to cyclosporin A. Furthermore, transcripts and protein of the common CN B subunit and of the testis-specific form of CN B subunit were analyzed. The common CN B subunit transcripts and protein are detected in all tissues. Transcripts for the 'testis-specific' CN B subunit are also found in brain, lung, thymus and heart, while the protein is only detected in testis. This indicates that the testis-specific CN B subunit gene expression is regulated at both transcriptional and posttranscriptional levels. The findings demonstrate that CN is a widely distributed protein phosphatase and that its activity is regulated in a tissue-specific manner.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607217     DOI: 10.1111/j.1432-1033.1995.0469h.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Ran and calcineurin can participate collaboratively in the regulation of spermatogenesis in scallop.

Authors:  Hirotsugu Hino; Kana Arimoto; Michio Yazawa; Yota Murakami; Akiko Nakatomi
Journal:  Mar Biotechnol (NY)       Date:  2012-01-15       Impact factor: 3.619

2.  A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

Authors:  J D Molkentin; J R Lu; C L Antos; B Markham; J Richardson; J Robbins; S R Grant; E N Olson
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

3.  Effects of sugammadex on immunoreactivity of calcineurin in rat testes cells after neuromuscular block: a pilot study.

Authors:  Yıldıray Kalkan; Levent Tümkaya; Habib Bostan; Yakup Tomak; Adnan Yılmaz
Journal:  J Mol Histol       Date:  2011-12-29       Impact factor: 2.611

4.  Characterization of a human regulatory subunit of protein phosphatase 3 gene (PPP3RL) expressed specifically in testis.

Authors:  Lingling Liu; Jianxuan Zhang; Jian Yuan; Yongjun Dang; Chenyi Yang; Xiujuan Chen; Jianing Xu; Long Yu
Journal:  Mol Biol Rep       Date:  2005-03       Impact factor: 2.316

5.  Treatment of hippocampal neurons with cyclosporin A results in calcium overload and apoptosis which are independent on NMDA receptor activation.

Authors:  B Kaminska; I Figiel; B Pyrzynska; R Czajkowski; G Mosieniak
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

Review 6.  Potential role of calcineurin in pathogenic conditions.

Authors:  Khaliq Kurji; Rajendra K Sharma
Journal:  Mol Cell Biochem       Date:  2009-12-05       Impact factor: 3.396

7.  Calcineurin inhibitor-mediated bilateral hippocampal injury after bone marrow transplantation.

Authors:  S-H Lee; B-C Kim; D-H Yang; M-S Park; S-M Choi; M-K Kim; K-H Cho
Journal:  J Neurol       Date:  2008-05-06       Impact factor: 6.682

8.  Effects of FK506 on Hippocampal CA1 Cells Following Transient Global Ischemia/Reperfusion in Wistar Rat.

Authors:  Zahra-Nadia Sharifi; Farid Abolhassani; Mohammad Reza Zarrindast; Shabnam Movassaghi; Nasrin Rahimian; Gholamreza Hassanzadeh
Journal:  Stroke Res Treat       Date:  2011-09-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.